Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 2
1981 1
1982 3
1983 3
1984 1
1985 5
1986 10
1987 12
1988 13
1989 16
1990 16
1991 21
1992 30
1993 38
1994 39
1995 52
1996 59
1997 62
1998 76
1999 74
2000 103
2001 88
2002 115
2003 139
2004 178
2005 219
2006 265
2007 285
2008 331
2009 402
2010 416
2011 550
2012 657
2013 768
2014 932
2015 1026
2016 1110
2017 1204
2018 1319
2019 1599
2020 1923
2021 2231
2022 2649
2023 2705
2024 3022
2025 67

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22,244 results

Results by year

Filters applied: . Clear all
Page 1
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Cheng Y, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Osypchuk Y, Sinielnikov I, Yang TS, Liang X, Chen C, Wang L, Cheng AL, Kaseb A, Vogel A; CARES-310 Study Group. Qin S, et al. Among authors: lin x. Lancet. 2023 Sep 30;402(10408):1133-1146. doi: 10.1016/S0140-6736(23)00961-3. Epub 2023 Jul 24. Lancet. 2023. PMID: 37499670 Clinical Trial.
IL-17RA-signaling in Lgr5+ intestinal stem cells induces expression of transcription factor ATOH1 to promote secretory cell lineage commitment.
Lin X, Gaudino SJ, Jang KK, Bahadur T, Singh A, Banerjee A, Beaupre M, Chu T, Wong HT, Kim CK, Kempen C, Axelrad J, Huang H, Khalid S, Shah V, Eskiocak O, Parks OB, Berisha A, McAleer JP, Good M, Hoshino M, Blumberg R, Bialkowska AB, Gaffen SL, Kolls JK, Yang VW, Beyaz S, Cadwell K, Kumar P. Lin X, et al. Immunity. 2022 Feb 8;55(2):237-253.e8. doi: 10.1016/j.immuni.2021.12.016. Epub 2022 Jan 25. Immunity. 2022. PMID: 35081371 Free PMC article.
Proportional cross-ratio model.
Hu T, Nan B, Lin X. Hu T, et al. Among authors: lin x. Lifetime Data Anal. 2019 Jul;25(3):480-506. doi: 10.1007/s10985-018-9451-6. Epub 2018 Sep 7. Lifetime Data Anal. 2019. PMID: 30194655 Free PMC article.
Cellular senescence and acute kidney injury.
Lin X, Jin H, Chai Y, Shou S. Lin X, et al. Pediatr Nephrol. 2022 Dec;37(12):3009-3018. doi: 10.1007/s00467-022-05532-2. Epub 2022 Mar 26. Pediatr Nephrol. 2022. PMID: 35338388 Free PMC article. Review.
Superscattering of light: fundamentals and applications.
Wang C, Chen X, Gong Z, Chen R, Hu H, Wang H, Yang Y, Tony L, Zhang B, Chen H, Lin X. Wang C, et al. Among authors: lin x. Rep Prog Phys. 2024 Nov 18;87(12). doi: 10.1088/1361-6633/ad8eda. Rep Prog Phys. 2024. PMID: 39499962 Review.
22,244 results
You have reached the last available page of results. Please see the User Guide for more information.